STANDARD BIOTLS (LAB)
(Delayed Data from NSDQ)
$1.40 USD
-0.01 (-0.71%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.38 -0.02 (-1.43%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LAB 1.40 -0.01(-0.71%)
Will LAB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LAB
Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates
Doximity (DOCS) Q1 Earnings and Revenues Top Estimates
LAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Illumina Stock May Benefit From New Agreement to Acquire SomaLogic
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates
Strength Seen in American Well (AMWL): Can Its 18.8% Jump Turn into More Strength?
Other News for LAB
LAB forms Upper Bollinger Band Walk on September 19
180 Bullish Setup appears for LAB after 4.44% move
200 Day Moving Average Support appears for LAB after 2.17% move
LAB forms 200 Day Moving Average Support on September 16
Standard BioTools Announces Workforce Reduction Plan